Melissa E Dichter1, Terri N Haywood2, Anneliese E Butler2, Scarlett L Bellamy3, Katherine M Iverson4. 1. US Department of Veterans Affairs, Center for Health Equity Research and Promotion, Philadelphia, Pennsylvania; Department of Family Medicine and Community Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: melissa.dichter@va.gov. 2. US Department of Veterans Affairs, Center for Health Equity Research and Promotion, Philadelphia, Pennsylvania. 3. Department of Epidemiology and Biostatistics, Drexel University, Dornsife School of Public Health, Philadelphia, Pennsylvania. 4. US Department of Veterans Affairs, National Center for PTSD, VA Boston Healthcare System, Boston, Massachusetts; Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts.
Abstract
INTRODUCTION: Intimate partner violence (IPV) includes psychological, physical, or sexual aggression by a current or former intimate partner and is associated with a wide range of health and social impacts, especially for women. Women veterans may be at increased risk for experiencing IPV, and some Veterans Health Administration (VHA) facilities have initiated routine screening of female patients for past-year IPV. This study presents the first examination of clinical IPV screening responses recorded from female VHA patients across 13 facilities nationwide, and identifies associations with patient demographic and military service characteristics. METHODS: Electronic medical record data were extracted for a cohort of 8,885 female VHA patients who completed screening for experience of past-year IPV during a clinic visit between April 2014 and April 2016. Analyses, conducted in 2016, examined the overall proportion of patients screening positive for IPV, as well as associations by demographic and military service characteristics. RESULTS: Overall, 8.7% of patients screened positive for past-year IPV. Odds of screening positive for IPV were higher among women who were younger (aged <35 years); married; served in the most recent conflict era; experienced sexual assault or harassment during military service; or had not served in the military (non-veterans). CONCLUSIONS: Study findings indicate a significant proportion of female VHA patients disclosing past-year IPV during clinical screening, and identify characteristics associated with increased vulnerability. Implications for future research and program implementation include addressing high-risk subpopulations and further investigating the impact of screening and follow-up care. Published by Elsevier Inc.
INTRODUCTION: Intimate partner violence (IPV) includes psychological, physical, or sexual aggression by a current or former intimate partner and is associated with a wide range of health and social impacts, especially for women. Women veterans may be at increased risk for experiencing IPV, and some Veterans Health Administration (VHA) facilities have initiated routine screening of female patients for past-year IPV. This study presents the first examination of clinical IPV screening responses recorded from female VHA patients across 13 facilities nationwide, and identifies associations with patient demographic and military service characteristics. METHODS: Electronic medical record data were extracted for a cohort of 8,885 female VHA patients who completed screening for experience of past-year IPV during a clinic visit between April 2014 and April 2016. Analyses, conducted in 2016, examined the overall proportion of patients screening positive for IPV, as well as associations by demographic and military service characteristics. RESULTS: Overall, 8.7% of patients screened positive for past-year IPV. Odds of screening positive for IPV were higher among women who were younger (aged <35 years); married; served in the most recent conflict era; experienced sexual assault or harassment during military service; or had not served in the military (non-veterans). CONCLUSIONS: Study findings indicate a significant proportion of female VHA patients disclosing past-year IPV during clinical screening, and identify characteristics associated with increased vulnerability. Implications for future research and program implementation include addressing high-risk subpopulations and further investigating the impact of screening and follow-up care. Published by Elsevier Inc.
Authors: Katherine M Iverson; Omonyêlé Adjognon; Alessandra R Grillo; Melissa E Dichter; Cassidy A Gutner; Alison B Hamilton; Shannon Wiltsey Stirman; Megan R Gerber Journal: J Gen Intern Med Date: 2019-08-16 Impact factor: 5.128
Authors: Melissa E Dichter; Anneliese E Sorrentino; Terri N Haywood; Scarlett L Bellamy; Elina Medvedeva; Christopher B Roberts; Katherine M Iverson Journal: J Gen Intern Med Date: 2018-02-08 Impact factor: 5.128
Authors: Melissa E Dichter; Lena Makaroun; Anaïs Tuepker; Gala True; Ann Elizabeth Montgomery; Katherine Iverson Journal: J Gen Intern Med Date: 2020-06-08 Impact factor: 5.128
Authors: Katherine M Iverson; Melissa E Dichter; Kelly Stolzmann; Omonyêlé L Adjognon; Robert A Lew; LeAnn E Bruce; Megan R Gerber; Galina A Portnoy; Christopher J Miller Journal: Implement Sci Date: 2020-05-07 Impact factor: 7.327
Authors: Galina A Portnoy; Katherine M Iverson; Sally G Haskell; Maggie Czarnogorski; Megan R Gerber Journal: Public Health Rep Date: 2020-11-18 Impact factor: 2.792